009290.KS
Kwang Dong Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,340.00
+0.79%Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- KRW 54
- EPS estimate
- —
- Revenue actual
- KRW 439.8B
- Revenue estimate
- KRW 244.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 2
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 12, 2026